Publications by authors named "Anne Meibohm"

Claim this Profile
S
Standardization and Prediction to Control Confounding: Estimating Risk Differences and Ratios for Clinical Interpretations and Decision Making.
A Russell Localio, James A Henegan, Stephanie Chang, Anne R Meibohm, Eric A Ross

Ann Intern Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies Using Randomized Trial Data to Compare Nonrandomized Exposures.
Catharine B Stack, Anne R Meibohm, Joshua M Liao, Eliseo Guallar

Ann Intern Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding the Pathway: Mediation Analyses in Randomized Controlled Trials.
A Russell Localio, Anne R Meibohm, Eliseo Guallar

Ann Intern Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions.
A Russell Localio, Catharine B Stack, Anne R Meibohm, Eric A Ross, Eliseo Guallar

Ann Intern Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical Code to Support the Scientific Story.
A Russell Localio, Steven N Goodman, Anne Meibohm, John E Cornell, Catharine B Stack

Ann Intern Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TPO concentrations and response to romiplostim.
David J Kuter, Anne Meibohm, Angela Lopez

Am J Hematol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Random-effects meta-analysis of inconsistent effects: a time for change.
John E Cornell, Cynthia D Mulrow, Russell Localio, Catharine B Stack, Anne R Meibohm

Ann Intern Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
Christine Laine, Eliseo Guallar, Cynthia Mulrow, Darren B Taichman, John E Cornell, Anne R Meibohm

Ann Intern Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control study.
Mindy G Schuster, Anne Meibohm, Lisa Lloyd, Brian Strom

J Infect· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.
Jose M Gatell, Christine Katlama, Beatriz Grinsztejn, Joseph J Eron, Adriano Lazzarin, Anne R Meibohm

J Acquir Immune Defic Syndr· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
Stan L Block, Darron R Brown, Archana Chatterjee, Michael A Gold, Heather L Sings, Anne Meibohm

Pediatr Infect Dis J· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa.
Ellie J C Goldstein, Diane M Citron, Victoria Peraino, Tanya Elgourt, Anne R Meibohm

Antimicrob Agents Chemother· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Roy T Steigbigel, David A Cooper, Princy N Kumar, Joseph E Eron, Mauro Schechter, Anne R Meibohm

N Engl J Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
David A Cooper, Roy T Steigbigel, Jose M Gatell, Jurgen K Rockstroh, Christine Katlama, Anne R Meibohm

N Engl J Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of long-term combination antiretroviral therapy in asymptomatic treatment-naïve adults with early HIV infection.
Deborah K McMahon, Mark J Dinubile, Anne R Meibohm, Deborah R Marino, Michael N Robertson

HIV Clin Trials· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Paul M Coplan, John R Cook, George W Carides, Joseph F Heyse, Albert W Wu, Anne R Meibohm

Clin Infect Dis· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Joseph Solomkin, Hedy Teppler, Donald R Graham, Richard M Gesser, Anne R Meibohm

J Antimicrob Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of ertapenem.
Hedy Teppler, Richard M Gesser, Ian R Friedland, Gail L Woods, Anne Meibohm

J Antimicrob Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
Roy M Gulick, Anne Meibohm, Diane Havlir, Joseph J Eron, Audrey Mosley

AIDS· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis